-
Mashup Score: 11
Collaboration combines Teva’s expertise in respiratory technology development and Launch Therapeutics’ innovative late-stage drug development model to progress Teva’s Dual-Action Asthma Rescue Inhaler (TEV-‘248) program Development funding agreement to provide up to $150 million to offset program costs and to accelerate clinical research for Teva’s TEV-‘248 program in line with Teva’s Pivot to Growth strategy to step up innovation and advance its innovative pipeline Teva’s TEV-‘248 has the potential to be the first Dual-Action Asthma Rescue Inhaler combining an Inhaled Corticosteroid with a Short-Acting Beta-Agonist (ICS-SABA) for both adult and pediatric asthma indications Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Launch Therapeutics, Inc., today announced a clinical collaboration agreement to further accelerate the clinical research program of Teva’s ICS-SABA (TEV-‘248). Teva and Abingworth, a leading international life sciences investment group, part of global
Source: ir.tevapharm.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 12Combinations of air pollutants impact pediatric asthma symptoms - 1 month(s) ago
Researchers used machine learning to identify 25 combinations of air pollutants that were associated with increased asthma symptoms among children in Spokane, Washington, according to a study published in Science of the Total Environment.Also, a vulnerable sub-population was exposed to 13 of these combinations, Solmaz Amiri, DDes, MSc, research assistant professor, Institute for Research and
Source: www.healio.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 4
Review Articles Medication Non-adherence and predictor factors among adult Asthmatic patients in Ethiopia: a Systematic review and Meta-AnalysisChernet Tafere, Bereket Bahiru, Adane Yehualaw, Desalegn Getnet Demsie, Kebede Feyisa, Malede Berihun Yismaw, Endalamaw Aschale, Zenaw De …
Source: interasma.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 3Stepwise Asthma Control | AAAAI - 1 month(s) ago
AAAAI experts explain the stepwise approach for asthma control.
Source: www.aaaai.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 7Asthma is a Condition of Phenotypes & Targeted Treatments - 2 month(s) ago
The AAAAI offers articles written and reviewed by experts on asthma phenotypes.
Source: www.aaaai.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 6Biologics Linked to Remission at 1 Year in 19% of Patients With Severe Asthma - GAA Interasma - 2 month(s) ago
Colby Stong About 19% of patients with severe asthma achieved clinical remission and 79% had a clinical response after 1 year of biologic therapy, according to a study in Chest. Investigators identified the level of clinical remission in patients with severe asthma who used biologics, as well as predictors of …
Source: interasma.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 1Gas Stoves Emit Nanocluster Aerosol That May Increase Risk of Asthma, Respiratory Illness | Docwire News - 2 month(s) ago
A study found that cooking on a gas stoves can increase susceptibility to asthma or other respiratory illnesses.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 5Occupational Asthma | AAAAI - 2 month(s) ago
AAAAI, the experts in allergy and immunology, provide an overview of occupational asthma.
Source: www.aaaai.orgCategories: General Medicine News, Allergy-ImmunologyTweet-
Occupational #asthma is caused by inhaling fumes, gases, dust or other potentially harmful substances on the job. Often, your symptoms are worse during the days or nights you work, improve when you have time off and start again when you go back to work. https://t.co/ajuYwyVQNv https://t.co/xzDEidiC5o
-
-
Mashup Score: 5
This new issue contains the following articles:Article CommentaryEnhancing asthma research and improving health equity through decentralized clinical trials (DCTs) and mHealth technologyEmily R. Hunt, BS, Sara L. Hantgan & Sunit P. Jariwala, MDPages: 265-270 | DOI: 10.1080/02770903.2023.2267122Review Article …
Source: interasma.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 7What's Changed in Asthma Treatment? Quite a Bit - 2 month(s) ago
For primary care, Dr Neil Skolnik highlights the essential asthma treatment changes in the latest GINA guidelines, and the four questions to ask to assess asthma control.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
Today Teva announced a clinical collaboration agreement with Launch Therapeutics and a strategic funding development agreement with @Abingworthbio to accelerate development of our dual-action asthma rescue inhaler respiratory program. Read more: https://t.co/0KqB2lyypD #Asthma https://t.co/ZdDurPB4dt